Funded Tech Companies
Scarlet Therapeutics
Scarlet Therapeutics, based in Bristol, received equity investments from Meltwind Advisory and Science Creates Ventures.
Company Overview
Company Name
Scarlet Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Science Creates Old Market Midland Rd
Bristol, BS2 0JZ
UK
Bristol, BS2 0JZ
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Scarlet Therapeutics is developing a unique platform that generates novel red blood cell-based therapeutics to potentially treat a wide range of diseases. Initially targeted at the rare metabolic diseases, hyperammonemia and hyperoxaluria, this approach could also be used more broadly to target other metabolic diseases, cancer and autoimmune diseases. These therapeutic red blood cells (tRBCs) are very similar to standard red blood cells, having many unique qualities compared to systemic administration of therapeutic protein, including pervasive reach throughout the body, a long life and the ability to carry the active proteins within the tRBC, thereby shielding them from the immune system. Born out of more than a decade of research at the University of Bristol and its learnings from the RESTORE clinical study, Scarlet also has an exclusive commercial licence for the widely used BEL-A cell line, which provides an alternative platform technology for production of red blood cells.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/23/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alistair Irvine
Chief Scientific Officer
Ash Toye
Chief Technical Officer
Jan Frayne
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs